Research

Researches

Research News

18 Jan 2019

Hein Min Tun visited the National Centre for Infectious Diseases (NCID) of Singapore

Hein Min Tun, team leader at HKU-Pasteur, has been welcomed at the National Centre for Infectious Diseases (NCID) of Singapore in order to promote research collaboration in infectious diseases, microbiome, and antimicrobial resistance. The trip was funded by NCID Short Term Fellowship.

Hein had the opportunity to give three lectures covering two topics entitled Microbiome and Resistome Research in One Health: Opportunities and Challengesand Role of Gut Microbiome in the Developmental Origins of Health and Disease to the staffs of the National Centre for Infectious Diseases (NCID), the National University Hospital (NUH) and the National University of Singapore (NUS).

This visit was also the occasion to engage in group discussions with Prof Raymond Lin (NUH), Dr Janette Teo (NUH), Prof Gan Yunn Hwen (NUS), and Dr Benedict Yan, Head of Molecular Diagnosis Centre (NUH) as well as other clinicians and scientists and discussed possible research collaborations. 

10 Jan 2019

23rd Research Postgraduate Symposium: Congratulations Athena!

The Research Postgraduate Symposium (RPS), annual event established in 1996 at the Li Ka Shing Faculty of Medicine of The University of Hong Kong, has been held for the 23rd time in early December, 2018. It is the occasion for HKU’s young scientists to engage in a poster presentation session to showcase their research.

After Dr Selim last year, we can now congratulate another HKU-Pasteur team member, Athena Li, who got the best poster presentation award for her poster entitled Immunogenicity of alternative influenza vaccination strategies in the elderly and the establishment of immune responses, showing the progress she has made on her PhD project.

Summary: Inactivated seasonal influenza vaccines with enhanced immunogenicity are now available to older adults which aim to improve protection. Besides increasing antibodies to the head of hemaglutinin (HA) protein, immune mechanisms that contribute to their improved immunogenicity remain to be described. We have designed a clinical trial to compare immune responses of older adults receiving either the standard-dose vaccine or one of three enhanced vaccines (adjuvanted, high-dose HA or recombinant HA). The poster describes how these different vaccines affect the magnitude, function and quality of antibody responses following vaccination. 

Congratulations Athena!